Humana to study adverse reactions

In an unprecedented initiative, the University of Miami and Humana are joining forces to study drug safety and adverse reactions. Researchers will track Humana's database of 11 million members, looking for dangerous side effects that become apparent only after a drug has been used for some time. Dubbed the Pharmacovigilance Initiative, the program is an attempt to reach beyond voluntary reporting of adverse drug reactions. Results will be reported publicly via press releases and a special website beginning in 2008.

- check out the release on the program
- here's the report on the initiative from the South Florida Business Journal

Related Articles:
Humana, University of Miami take on 'pre-sick.' Report
Pharmacovigilance grows in importance. Report

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Novo Nordisk is betting big on GLP-1 Saxenda in its global obesity push, but England's cost watchdog is unimpressed with the drug's long-term outlook.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.